🇺🇸 FDA
Patent

US 10363289

Mutant OPAA enzyme with increased catalytic efficiency on GP

granted A61KA61K38/46A61P

Quick answer

US patent 10363289 (Mutant OPAA enzyme with increased catalytic efficiency on GP) held by The United States of America as represented by the Secretary of the Army expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/46, A61P, A61P43/00